Exagen Reaches 1M Patient Tested Vy AVISE CTD Milestone

BenzingaDec 12 22:02

Exagen Inc. Achieves Key Milestone With 1,000,000th Patient Tested by AVISE CTD

GlobeNewswireDec 12 22:00

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking AlphaNov 16 04:55

Exagen Inc. (NASDAQ:XGN) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall StNov 15 19:13

Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo FinanceNov 15 18:50

Express News | Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the Avise® Ctd Platform

BreakingsNov 15 05:30